Literature DB >> 7575446

A novel phospholipase A2 from human placenta.

W J Buhl1, L M Eisenlohr, I Preuss, U Gehring.   

Abstract

A major soluble phospholipase A2 of human term placenta was characterized and purified about 15,000-fold to homogeneity. The apparent molecular mass as determined in SDS/polyacrylamide gels is 42 kDa. The enzyme is inhibited by dithiothreitol indicating the presence of disulphide bridges which are essential for activity. Studies with known phospholipase A2 inhibitors revealed no immediate relationship to either secretory or cytosolic phospholipases A2. The placental enzyme prefers liposomes of phosphatidylcholine and has a distinct preference for arachidonic acid in the sn-2 position. It tolerates various detergents. Roughly 10 microM Ca2+ is required for activity, but it cannot be replaced by Mg2+ or Mn2+; Zn2+, Cu2+ and Fe3+ are inhibitory. In immunoblots, the placental enzyme was not detected by two separate antisera specific for type-II phospholipases A2 but reacted very weakly with antisera directed against cytosolic phospholipase A2. From these data we suggest that this enzyme is a novel form of phospholipase A2 which may be involved in arachidonic acid mobilization both during the course of pregnancy and at parturition.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7575446      PMCID: PMC1136131          DOI: 10.1042/bj3110147

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  51 in total

Review 1.  Control of vascular resistance in the human placenta.

Authors:  L Myatt
Journal:  Placenta       Date:  1992 Jul-Aug       Impact factor: 3.481

2.  Applications of metal buffers and metal indicators in biochemistry.

Authors:  J RAAFLAUB
Journal:  Methods Biochem Anal       Date:  1956

3.  Purification and partial characterization of phospholipase A2 isoforms from human placenta.

Authors:  L M Jordan; F Russo-Marie
Journal:  J Chromatogr       Date:  1992-04-24

4.  Purification and characterization of rabbit platelet cytosolic phospholipase A2.

Authors:  D K Kim; I Kudo; K Inoue
Journal:  Biochim Biophys Acta       Date:  1991-04-24

5.  Epidermal growth factor enhances glomerular mesangial cell soluble phospholipase A2 activity.

Authors:  J V Bonventre; J H Gronich; R A Nemenoff
Journal:  J Biol Chem       Date:  1990-03-25       Impact factor: 5.157

Review 6.  New insights on mammalian phospholipase A2(s); comparison of arachidonoyl-selective and -nonselective enzymes.

Authors:  R J Mayer; L A Marshall
Journal:  FASEB J       Date:  1993-02-01       Impact factor: 5.191

7.  Methylation of histidine-48 in pancreatic phospholipase A2. Role of histidine and calcium ion in the catalytic mechanism.

Authors:  H M Verheij; J J Volwerk; E H Jansen; W C Puyk; B W Dijkstra; J Drenth; G H de Haas
Journal:  Biochemistry       Date:  1980-02-19       Impact factor: 3.162

8.  Purification and some properties of a phospholipase A2 from bovine platelets.

Authors:  D K Kim; P G Suh; S H Ryu
Journal:  Biochem Biophys Res Commun       Date:  1991-01-15       Impact factor: 3.575

9.  Properties and purification of an arachidonoyl-hydrolyzing phospholipase A2 from a macrophage cell line, RAW 264.7.

Authors:  C C Leslie; D R Voelker; J Y Channon; M M Wall; P T Zelarney
Journal:  Biochim Biophys Acta       Date:  1988-12-16

10.  Thromboxane A2 synthesis in pregnancy-induced hypertension.

Authors:  D J Fitzgerald; W Rocki; R Murray; G Mayo; G A FitzGerald
Journal:  Lancet       Date:  1990-03-31       Impact factor: 79.321

View more
  2 in total

1.  Bovine retinal pigment epithelium contains novel types of phospholipase A2.

Authors:  M Jacob; P K Weech; C Salesse
Journal:  Biochem J       Date:  1997-10-15       Impact factor: 3.857

2.  The genome of the live-bearing fish Heterandria formosa implicates a role of conserved vertebrate genes in the evolution of placental fish.

Authors:  Henri van Kruistum; Joost van den Heuvel; Joseph Travis; Ken Kraaijeveld; Bas J Zwaan; Martien A M Groenen; Hendrik-Jan Megens; Bart J A Pollux
Journal:  BMC Evol Biol       Date:  2019-07-26       Impact factor: 3.260

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.